Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Company receives Complete Response Letter from FDA for Deramiocel BLAConference call and webcast Monday, November 23, at 8:30 a.m.
Fastest customizable press release feed in the world.
Signed out · Sign up for real-time
Updates arrive automatically.
Company receives Complete Response Letter from FDA for Deramiocel BLAConference call and webcast Monday, November 23, at 8:30 a.m.
In the news release, Sidus Space Expands Aerospace Customer Base with Argotec Order, issued 19-Nov-2026 by Sidus Space, Inc. over PR Newswire, we are advised by the company that the image has been updated. The complete, corrected release follows:Sidus Space Expands Aerospace Customer Base with Argotec OrderSidus extends nearly 15 years of aerospace manufacturing, proven on its own LizzieSat satellites in orbit, to a new international customer.
JBS N.V. (the "Company," "JBS," "we" or "us") (NYSE:JBS, B3: JBSS32)), together with JBS USA Foods Group Holdings, Inc. and JBS USA Food Company Holdings (collectively, the "Co-Issuers"), announced today the expiration and results of its previously announced offers to exchange (the "Exchange Offers") any and all of the outstanding Old Notes (as defined below) for an equal principal amount of new notes (the "New Notes") in a transaction registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Exchange Offers expired at 5:00 p.m., New York City time, on November 20, 2026 (the "Expiration Date"). As of
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) (the "Company") today announced that it received written notice dated November 20, 2026, from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1), because the Company filed its Form 20-F for the year ended December 31, 2025 on November 18, 2026. Accordingly, Nasdaq has closed the matter relating to the delayed filing of the Company’s annual report. The Company remains subject to the previously disclosed minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2) and has until April 5, 2027 t
Surgery Partners, Inc. ("Surgery Partners") (NASDAQ:SGRY) announced today the results of the previously announced solicitation of consents (the "Consent Solicitation") by its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the "Issuer"), from holders ("Holders") of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the "Notes") to certain proposed amendments (the "Proposed Amendments") to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the "Indenture"),
Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a best-efforts public offering (the "Offering") of $5.0 million for its client Fitness Champs Holdings Limited (NASDAQ:FCHL) (the "Company" or "Fitness Champs"), a distinguished aquatic sports education provider in Singapore. The Offering is comprised of 14,285,715 units (each, a "Unit"), consisting of one Class A ordinary share of the Company, par value $0.00225 per share (the "Class A Ordinary Shares"), or in lieu thereof, a pre-funded warrant, and one warrant to
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), is pleased to announce the acquisition of a Vive Collision property for $3.9 million. The property is located in a strong retail corridor in New Jersey and corporate-operated under a long-term, triple net lease with approximately 19 years of term remaining. The transaction was priced at a 6.9% cap rate on rent as of the closing date and exclusive of transaction costs. About FCPT FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the own
Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that it has received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market. On May 19, 2026, the Company previously disclosed that, on May 15, 2026, the Company received a letter from Nasdaq notifying the Company that based on the closing bid price of the ordinary shares of the Company for the prior 30 consec
Third-quarter revenue of $11.2 million increased from $8.2 million in the second quarter; year-over-year results continued to reflect lower residential demand following the expiration of the Section 25D federal residential tax credit. Commercial revenue increased 20% year-over-year to $2.7 million; SG&A expense declined 37% year-over-year to $4.3 million. Results included $9.8 million of non-cash goodwill and intangible asset impairment charges. SUNation continues to prioritize liquidity, cost management, and execution of its proposed merger with
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ("TIL") therapies for patients with cancer, today announced that on November 19, 2026 (the "Date of Grant"), the Company approved the grant of inducement stock options covering an aggregate of 175,840 shares of Iovance’s common stock to twenty-two new, non-executive employees. The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees of Iovance by th
Brainstorm Cell Therapeutics Inc. (OTCQB:BCLI) has released the following notice. The full Notice of Pendency and Proposed Settlement of Stockholder Derivative Matters and the Stipulation and Agreement of Settlement, with its exhibits, are available at https://brainstorm-cell.com/investors/ . UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK IN RE BRAINSTORM CELL THERAPEUTICS, INC. DERIVATIVE LITIGATION Lead Case No. 1:24-cv-01095-DEHSUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE MATTERSEXHIBIT D TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF BRAINSTORM CELL THERAPEUTICS INC. ("BRAINSTORM" OR THE "COMP
Barrick Mining Corporation (NYSE:B)(TSX:ABX) has received notice of an unsolicited mini-tender offer made by New York Stock and Bond LLC ("NYSB") to purchase up to 50,000 of Barrick’s common shares at a below-market price of US$26.40 per share. NYSB’s below-market offer price of US$26.40 per share represents a discount of approximately 34.91% to the closing price of Barrick common shares on the New York Stock Exchange on November 6, 2026, the last trading day before the mini-tender offer was commenced. Barrick shareholders who tender their shares in this offer will receive a below-market price. Barrick recommends shareholders do not tender their
Power Integrations (Nasdaq: POWI) today announced that on November 15, 2026 (the Grant Date), it granted a total of 42,411 RSUs and 1,361 PSUs at target to a total of 15 employees who began their employment with Power Integrations in October 2026. The inducement grants were issued pursuant to Power Integrations’ Amended and Restated 2025 Inducement Award Plan. One-fourth (1/4th) of the RSUs will vest on each of the first four anniversaries of the respective Grant Dates, subject to the recipient’s continued service through each applicable vesting date. The PSUs will vest based upon achievement of the Company’s performance metrics for 2026, as determined by the Talent and Compensation Committee
Momentus Inc. (NASDAQ:MNTS) ("Momentus" or the "Company"), a U.S. commercial space company that offers satellite buses, transportation and other in-space infrastructure services, announced today the granting of inducement awards to nine new employees under Momentus’ 2022 Inducement Equity Plan. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Momentus’ Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company. In connection with the commencement of their employment, the employees received an aggregate of 2,350 restricted stock units ("RSUs"). The RSUs have a four-year annual vesting schedule, subject
AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "aa-" (Superior) of RiverSource Life Insurance Company (Minneapolis, MN) and its wholly owned subsidiary, RiverSource Life Insurance Co. of New York (Albany, NY). These companies represent the key life/health (L/H) insurance subsidiaries of Ameriprise Financial, Inc. (Ameriprise) (headquartered in Minneapolis, MN) (NYSE:AMP) and are collectively known as Ameriprise Financial Group. Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a+" (Excellent) of Ameriprise Captive Insurance Company (ACIC) (Burlington, VT), a property/casu
Business combination closed on November 20, 2026; Melar renamed Everli Global Holdings, Inc. Class A common stock and warrants expected to begin trading on the Nasdaq Global Market on Monday, November 23, 2026 under "EVRL" and "EVRLW"Melar units, Class A ordinary shares and warrants to cease trading under "MACIU," "MACI" and "MACIW" at the close of market today, November 20, 2026
In the news release, Blue Moon Completes its Acquisition of the Turner Copper-Gold VMS Deposit, issued 19-Nov-2026 by Blue Moon Metals over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:Blue Moon Completes its
Chord Energy Corporation (NASDAQ:CHRD) ("Chord," "Chord Energy," or the "Company") announced today that it's subsidiary has completed the previously announced sale of its entire non-operated Marcellus position to POSCO International Corporation for total gross consideration of $550MM. As previously disclosed, the transaction had an effective date of July 1, 2026, and Chord received a $55MM deposit in September. The cash consideration received at closing reflects purchase price adjustments and is net of the $55MM deposit previously received. Following the completion of the divestiture, Chord
As Lincoln gets ready for the Ohio State-Nebraska matchup, Bloom Energy is joining the community off the field to recognize the firefighters and first responders who help keep Nebraska’s capital safe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120207460/en/ On Friday, Bloom Energy visited Lincoln Fire & Rescue Station #1 and presented the department with a $10,000 donation. The contribution recognizes the more than 300 Lincoln Fire & Rescue personnel serving the city across 16 fire stations and supports the department’s continued work protecting the Lincoln community. "Lincoln’s firefighters have been called on in extra
Theriva™ Biologics, Inc. (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced today a reverse stock split of its authorized and issued and outstanding common stock, par value $0.001 per share, at a ratio of one (1) share of common stock for every thirty (30) shares of common stock, effective as of 11:59 p.m. (Eastern Time) on December 1, 2026 (the "Effective Date"). The Company’s common stock will begin trading on a split-adjusted basis when the market opens on December 2, 2026. The reverse stock split was authorized by the Company’